Tubacex (ES:TUB) has released an update.
Tubacex has concluded the first half of 2024 with a robust order book worth 1.6 billion euros and significant developments, including the initiation of a major contract with ADNOC and a strategic partnership with Mubadala Investment to enhance its OCTG business. The company reports sales of 398 million euros and an EBITDA of 50.1 million euros, looking forward to a stronger second half and positive expectations for 2025. Despite a challenging economic climate, Tubacex maintains a cautious but optimistic outlook, with the strategic plan NT2 set to steer the company towards growth and consolidation.
For further insights into ES:TUB stock, check out TipRanks’ Stock Analysis page.
